Click here to read MacularNEWS Spring 2020
To recognise our relationship to the University of Sydney, we have adopted the University’s brand identity. This is still the same MacularNEWS that you are used to, just with a new look.
This issue focuses on the results of our clinical trial into a potential treatment for diabetic macular oedema. Although the injections we currently use are extremely effective, they are expensive and invasive so anything that made them last longer would be a major advance.
To read the Spring 2020 edition of MacularNEWS, please click the button below.
Thank you for your support.
Professor Mark Gillies
Macula Research Group
In this issue:
- The results of our clinical trial into the use of near-infrared light as a treatment for diabetic macular oedema
- A reminder for people with diabetes to attend their eye examinations
- News of the Save Sight Institute's ACTA membership
- Meet the newest members of the Save Sight Registries team